Showing results (191-200 of 262) with videos related to

Sort By:
Pageof 27
The American Journal of Gastroenterology|April 27, 2023
Characteristics of Facilities With Early and Rapid Ustekinumab Adoption for Patients With Inflammatory Bowel DiseaseShirley Cohen-Mekelburg, Tony Van, Jeffrey A Berinstein, et al.
Radiology|February 18, 2011
Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn diseaseJeremy Adler, Scott D Swanson, Phyllissa Schmiedlin-Ren, et al.
Plos One|November 7, 2017
Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis CMonica A Konerman, Dongxia Lu, Yiwei Zhang, et al.
Inflammatory Bowel Diseases|January 12, 2022
Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin CancerKelly C Cushing, Xiaomeng Du, Yanhua Chen, et al.
Inflammatory Bowel Diseases|March 1, 2022
The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisJessica L Sheehan, Janson Jacob, Elliot M Berinstein, et al.
The American Journal of Gastroenterology|November 17, 2023
Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the PouchMaia Kayal, Parakkal Deepak, Poonam Beniwal-Patel, et al.
American Journal of Respiratory Cell and Molecular Biology|March 16, 2013
X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosisIyabode O Ajayi, Thomas H Sisson, Peter D R Higgins, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 30, 2021
A Care Coordination Intervention Improves Symptoms But Not Charges in High-Risk Patients With Inflammatory Bowel DiseaseJeffrey A Berinstein, Shirley A Cohen-Mekelburg, Gillian M Greenberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2018
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative ColitisStephen Hanauer, Remo Panaccione, Silvio Danese, et al.
Crohn'S & Colitis 360|March 31, 2023
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysisRemo Panaccione, Eric B Collins, Gil Y Melmed, et al.
Pageof 27